Search
for

    Sort by

    Research 781–810 of 1000+

    1. Effectiveness and safety of the combination therapy of micro-needling and minoxidil in androgenetic alopecia of Indonesian men: a randomized controlled trial Dermatology Reports · 2024
    2. A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia Journal of The American Academy of Dermatology · 2011 · 81 citations
    3. Anxiety, Depression, and Quality of Life in Women with Polycystic Ovarian Syndrome Indian Journal of Psychological Medicine · 2018 · 60 citations
    4. Altered resting-state activity in seasonal affective disorder Human Brain Mapping · 2012 · 31 citations
    5. Considerations on Hair Research and Hair Growth Springer eBooks · 1981 · 7 citations
    6. Comment on “Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial” Evidence-based Complementary and Alternative Medicine · 2015 · 3 citations
    7. Depression and anxiety, peripheral blood inflammatory factors, and stress levels on therapeutic outcomes in patients with chronic wounds World Journal of Psychiatry · 2024 · 2 citations
    8. Partial regrowth of scalp hair in a patient treated with extracorporeal pholtochemotherapy and interferon ? 2a Journal of The European Academy of Dermatology and Venereology · 1998 · 2 citations
    9. Correlation of Trichoscopic Findings with Disease Severity in Androgenetic Alopecia Pakistan Armed Forces Medical Journal · 2026
    10. Assessment of Nitric Oxide Synthase Protein Level in the Scalp of Androgenetic Alopecia QJM · 2025
    11. Hair Loss Treatment Uses Stem Cells to Generate Healthy New Follicles Genetic engineering & biotechnology news · 2022
    12. Androgenic alopecia--Its characteristics and perspectives Juntendo Medical Journal · 1992
    13. Tratamento de queimaduras de carboxiterapia em modelo experimental 2012 · 4 citations
    14. Hair cycle and dermic follicular volume of the wild rodent, agouti (Dasyprocta prymnolopha), raised in captivity, in the northeast region of Brazil Arquivo Brasileiro de Medicina Veterinária e Zootecnia · 2025
    15. Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? Journal of the International Society of Sports Nutrition · 2024
    16. The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection ˜The œAmerican journal of medicine · 1999 · 64 citations
    17. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1) Journal of the American Academy of Dermatology · 2024 · 63 citations
    18. Response of Sows and Litters to Added Dietary Biotin in Environmentally Regulated Facilities Journal of Animal Science · 1984 · 30 citations
    19. Biochemical examination of fetal skin biopsy specimens obtained by fetoscopy: Use of the method for analysis of keratins and filaggrin Prenatal Diagnosis · 1986 · 7 citations
    20. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial Journal of the American Academy of Dermatology · 2025 · 2 citations
    21. 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Journal of the American Academy of Dermatology · 2024 · 2 citations
    22. 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2024 · 2 citations
    23. 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial Journal of the American Academy of Dermatology · 2023 · 2 citations
    24. 62339 Improvement in anxiety and depression in adult patients with severe alopecia areata treated with deuruxolitinib: Pooled data from the THRIVE-AA1 and THRIVE-AA2 Phase 3 trials Journal of the American Academy of Dermatology · 2025
    25. 60058 Change in patient-reported hair satisfaction during deuruxolitinib treatment of severe alopecia areata: Pooled data from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials Journal of the American Academy of Dermatology · 2025
    26. 42736 Safety Assessments in the Multinational Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    27. 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    28. Issue Information Allergy · 2023
    29. Trichohyalin: Purification from Porcine Tongue Epithelium and Characterization of the Native Protein 2021
    30. Mrp3, a Mitogen-Regulated Protein/Proliferin Gene Expressed in Wound Healing and in Hair Follicles* Endocrinology · 2001 · 34 citations